Course Hero Logo

Multifaceted highly targeted sequential multidrug treatment of ea.pdf

Course Hero uses AI to attempt to automatically extract content from documents to surface to you and others so you can study better, e.g., in search results, to enrich docs, and more. This preview shows page 1 - 3 out of 16 pages.

Henry Ford HealthHenry Ford HealthHenry Ford Health Scholarly CommonsHenry Ford Health Scholarly CommonsInfectious Diseases ArticlesInfectious Diseases12-30-2020Multifaceted highly targeted sequential multidrug treatment ofMultifaceted highly targeted sequential multidrug treatment ofearly ambulatory high-risk SARS-CoV-2 infection (COVID-19)early ambulatory high-risk SARS-CoV-2 infection (COVID-19)Peter A. McCulloughPaul E. AlexanderRobin ArmstrongCristian ArvinteAlan F. BainSee next page for additional authorsFollow this and additional works at:infectiousdiseases_articlesRecommended CitationRecommended CitationMcCullough PA, Alexander PE, Armstrong R, Arvinte C, Bain AF, Bartlett RP, Berkowitz RL, Berry AC, BorodyTJ, Brewer JH, Brufsky AM, Clarke T, Derwand R, Eck A, Eck J, Eisner RA, Fareed GC, Farella A, FonsecaSNS, Geyer CE, Jr., Gonnering RS, Graves KE, Gross KBV, Hazan S, Held KS, Hight HT, Immanuel S, JacobsMM, Ladapo JA, Lee LH, Littell J, Lozano I, Mangat HS, Marble B, McKinnon JE, Merritt LD, Orient JM,Oskoui R, Pompan DC, Procter BC, Prodromos C, Rajter JC, Rajter JJ, Ram CVS, Rios SS, Risch HA, RobbMJA, Rutherford M, Scholz M, Singleton MM, Tumlin JA, Tyson BM, Urso RG, Victory K, Vliet EL, Wax CM,Wolkoff AG, Wooll V, and Zelenko V. Multifaceted highly targeted sequential multidrug treatment of earlyambulatory high-risk SARS-CoV-2 infection (COVID-19). Rev Cardiovasc Med 2020; 21(4):517-530.This Article is brought to you for free and open access by the Infectious Diseases at Henry Ford Health ScholarlyCommons. It has been accepted for inclusion in Infectious Diseases Articles by an authorized administrator ofHenry Ford Health Scholarly Commons.
AuthorsAuthorsPeter A. McCullough, Paul E. Alexander, Robin Armstrong, Cristian Arvinte, Alan F. Bain, Richard P. Bartlett,Robert L. Berkowitz, Andrew C. Berry, Thomas J. Borody, Joseph H. Brewer, Adam M. Brufsky, TerynClarke, Roland Derwand, Alieta Eck, John Eck, Richard A. Eisner, George C. Fareed, Angelina Farella, SilviaNS Fonseca, Charles E. Geyer, Russell S. Gonnering, Karladine E. Graves, Kenneth BV Gross, Sabine Hazan,Kristin S. Held, H. Thomas Hight, Stella Immanuel, Michael M. Jacobs, Joseph A. Ladapo, Lionel H. Lee,John Littell, Ivette Lozano, Harpal S. Mangat, Ben Marble, John E. McKinnon, Lee D. Merritt, Jane M.Orient, Ramin Oskoui, Donald C. Pompan, Brian C. Procter, Chad Prodromos, Juliana Cepelowicz Rajter,Jean-Jacques Rajter, C. Venkata S. Ram, Salete S. Rios, Harvey A. Risch, Michael JA Robb, MollyRutherford, Martin Scholz, Marilyn M. Singleton, James A. Tumlin, Brian M. Tyson, Richard G. Urso, KellyVictory, Elizabeth Lee Vliet, Craig M. Wax, Alexandre G. Wolkoff, Vicki Wooll, and Vladimir ZelenkoThis article is available at Henry Ford Health Scholarly Commons:infectiousdiseases_articles/139

Upload your study docs or become a

Course Hero member to access this document

Upload your study docs or become a

Course Hero member to access this document

End of preview. Want to read all 16 pages?

Upload your study docs or become a

Course Hero member to access this document

Term
Spring
Professor
N/A
Tags
Clinical trial, Randomized controlled trial, Ambulatory

Newly uploaded documents

Show More

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture